PMDA — authorised 27 September 2017
- Marketing authorisation holder: AbbVie GK
- Status: approved
🇯🇵 Mavyret in Japan
PMDA authorised Mavyret on 27 September 2017
Marketing authorisation
Mavyret in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Mavyret approved in Japan?
Yes. PMDA authorised it on 27 September 2017.
Who is the marketing authorisation holder for Mavyret in Japan?
AbbVie GK holds the Japanese marketing authorisation.